Landmark study tracks HIV care in trans europeans

NCT ID NCT03922269

Completed Knowledge-focused Sponsor: Chelsea and Westminster NHS Foundation Trust Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 200 transgender and non-binary people living with HIV across Europe for 18 months. Researchers collected data from routine blood tests to see how well HIV treatment was working. The goal is to use these findings to create better treatment guidelines and design future studies for this community.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENDER IDENTITY HIV INFECTIONS HUMAN IMMUNODEFICIENCY VIRUS

Contacts and locations

Show contact details

Locations

Chelsea and Westminster Hospital

London, Greater London, SW10 9NH, United Kingdom
Elton John Centre, Brighton and Sussex University Hospitals

Brighton, Sussex, BN2 1DH, United Kingdom
Manchester University NHS Foundation Trust

Manchester, Greater Manchester, United Kingdom
Servizio Sanitario Nazionale Regione Piemonte Azienda Sanitaria Locale "Citta di Torino" Department of Medical Sciences, University of Turin

Torino, Italy